Test Price
2,800 AED✅ Home Collection Available
EIF2B1 Gene Leukoencephalopathy with Vanishing White Matter Genetic Test in UAE | 2,800 AED | 2026 DHA Guidelines
تحليل جين EIF2B1 لاعتلال المادة البيضاء المتلاشي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
Our 2026 DHA-aligned, ISO 9001:2015-certified laboratory provides the definitive EIF2B1 Genetic Test with 99.9% diagnostic sensitivity for vanishing white matter disease (VWM). We offer premium hospital-grade home collection across the UAE (8 AM – 11 PM), VIP phlebotomy, cold-chain logistics, and direct post-test clinical guidance. Verify insurance coverage instantly via WhatsApp: +971 54 548 8731.
باختصار: يوفر مختبرنا المعتمد من هيئة الصحة بدبي وفقًا لأحدث معايير 2026 فحصًا جينيًا عالي الدقة لجين EIF2B1 باستخدام التسلسل الجيني من الجيل التالي (NGS)، مع استشارة وراثية ما بعد الفحص، وجمع عينات منزلي VIP، وإرشاد إكلينيكي عبر الهاتف، بما يتوافق مع القانون الاتحادي رقم 41 لسنة 2024 ولائحة خصوصية البيانات الصحية.
Test Overview & Clinical Utility
This advanced DNA test sequences the entire coding region of the EIF2B1 gene using Next Generation Sequencing (NGS) to detect pathogenic mutations linked to childhood ataxia with central nervous system hypomyelination/vanishing white matter disease (VWM). It offers vital insights for molecular diagnosis, carrier detection, and informed family planning in suspected leukodystrophy cases.
الفحص الجيني لجين EIF2B1 يكشف الطفرات المرتبطة بمرض اختفاء المادة البيضاء في الدماغ، ويُستخدم للتشخيص الدقيق والتخطيط العائلي.
| Feature | Our DHA-Certified Test | Closest Alternative (Sanger) |
|---|---|---|
| Methodology | NGS (full gene sequencing, all exons + splice sites) | Sanger sequencing (known hotspot regions only) |
| Precision | 99.9% analytical sensitivity/specificity | Limited to preselected mutations |
| Turnaround Time | 3 – 4 weeks | 2 – 3 weeks (faster but narrower) |
| Cost (AED) | 2,800 AED | ~2,200 – 2,500 AED (limited scope) |
Physician Insight & Clinical Safety Protocol
From Dr. Prabhakar Reddy, Consultant Neurologist (DHA License: 61713011): “As a neurologist, I understand the profound anxiety that genetic testing for a rare leukodystrophy can bring. This NGS assay provides a definitive molecular diagnosis that is crucial for accurate prognostication, family counselling, and guiding potential disease‑modifying interventions. I strongly recommend integrating these results with a comprehensive clinical evaluation and a dedicated genetic counselling session.”
Medication Warning
Do not discontinue any prescribed medications or therapies without first consulting your treating physician, as abrupt changes may worsen neurological status.
Patient Safety & Exclusion Criteria
- This test is not intended for asymptomatic minors without clinical suspicion and informed parental consent, in strict compliance with UAE CDS Law 2026.
- It is not a standalone screening tool; negative or ambiguous results must be correlated by a neurologist.
- Emergency red flags: If you experience acute deterioration, seizures, loss of consciousness, or sudden vision changes, seek immediate emergency medical attention — do not wait for test results.
- Individuals without a verified clinical history or family pedigree suggestive of VWM should first undergo neurological and genetic counselling.
UAE Regulatory Compliance:
Our facility (License: 9834453) adheres to Federal Decree-Law No. 41 of 2024 (Art. 87), UAE CDS Law 2026 (minor consent mandates), and UAE PDPL data privacy standards. Certified ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). All genetic counselling and sample logistics comply with MOHAP regulations.
Patient FAQ & Clinical Guidance
Who should consider this EIF2B1 gene test?
Snippet answer: Individuals with unexplained progressive ataxia, spasticity, and brain MRI showing diffuse white matter rarefaction, or those with a known family history of vanishing white matter disease, should consider this test to confirm the diagnosis and enable genetic counseling.
من يجب أن يفكر في إجراء تحليل جين EIF2B1؟ الأفراد الذين يعانون من ترنح مترقٍ غير مفسر أو تشنجات، مع وجود تغيرات في المادة البيضاء بالرنين المغناطيسي، أو وجود تاريخ عائلي للمرض.
How accurate is NGS for detecting EIF2B1 mutations?
Snippet answer: Our NGS assay achieves >99.9% analytical sensitivity and specificity, comprehensively sequencing all coding exons and splice junctions, ensuring reliable detection of pathogenic variants.
ما مدى دقة فحص NGS لاكتشاف طفرات EIF2B1؟
How long until results and what support is provided?
Snippet answer: Results are available in 3-4 weeks; our service includes a post- telephonic clinical guidance session with a certified genetic counselor to interpret findings and discuss next steps.
متى تظهر النتائج وما الدعم المقدم بعد الفحص؟
Secure Your Appointment Today
VIP Home Collection • Direct Insurance Billing • 8 AM – 11 PM
+971 54 548 8731
DHA Licensed | ISO‑Certified Cold‑Chain Logistics
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians